drugset / Trial / NCT00274534

A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.

NCT00274534

Phase 3 Completed 36 enrolled Boehringer Ingelheim
RandomizedCrossoverDouble-blindTreatment

Summary

To evaluate changes in PaO2 following inhalation of Tiotropium by HandiHaler compared to Salmeterol MDI in patients with moderate to severe COPD.

Timeline

Start
2000-12
Primary completion
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Salmeterol Other / unclassified 50 ug Inhaled
Subject Tiotropium Other / unclassified 18 ug Inhaled